Evidence map›Paper›PMID 38499587›Full record

ArticleNature communications2024

Cryo-EM structures of type IV pili complexed with nanobodies reveal immune escape mechanisms.

David Fernandez-Martinez, Youxin Kong, Sylvie Goussard, Agustin Zavala, Pauline Gastineau, Martial Rey, Gabriel Ayme, Julia Chamot-Rooke, Pierre Lafaye, Matthijn Vos and 2 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Engineered Proteins Mimic ssRNA Phage to Disrupt Type IV Pili.bioRxiv : the preprint server for biology · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

David Fernandez-Martinez *Institut Pasteur, Université Paris Cité, INSERM UMR1225, Pathogenesis of Vascular Infections, 75015, Paris, France.
Youxin Kong *Institut Pasteur, Université Paris Cité, INSERM UMR1225, Pathogenesis of Vascular Infections, 75015, Paris, France.
Sylvie GoussardInstitut Pasteur, Université Paris Cité, INSERM UMR1225, Pathogenesis of Vascular Infections, 75015, Paris, France.
Agustin ZavalaInstitut Pasteur, Université Paris Cité, INSERM UMR1225, Pathogenesis of Vascular Infections, 75015, Paris, France.ORCID 0000-0003-1606-3244
Pauline GastineauInstitut Pasteur, Université Paris Cité, INSERM UMR1225, Pathogenesis of Vascular Infections, 75015, Paris, France.ORCID 0000-0001-6579-2756
Martial ReyInstitut Pasteur, Université Paris-Cité, CNRS, UAR 2024, Mass Spectrometry for Biology, 75015, Paris, France.ORCID 0000-0002-7378-1106
Gabriel AymeInstitut Pasteur, Université Paris-Cité, CNRS-UMR 3528, Antibody Engineering Platform, 75015, Paris, France.ORCID 0000-0002-0438-8095
Julia Chamot-RookeInstitut Pasteur, Université Paris-Cité, CNRS, UAR 2024, Mass Spectrometry for Biology, 75015, Paris, France.ORCID 0000-0002-9427-543X
Pierre LafayeInstitut Pasteur, Université Paris-Cité, CNRS-UMR 3528, Antibody Engineering Platform, 75015, Paris, France.ORCID 0000-0002-5761-1342
Matthijn VosNanoImaging Core Facility, Center for Technological Resources and Research, Institut Pasteur, 75015, Paris, France.
Ariel MechalyInstitut Pasteur, Crystallography Platform-C2RT, CNRS-UMR 3528, Université Paris Cité, Paris, France.
Guillaume DuménilInstitut Pasteur, Université Paris Cité, INSERM UMR1225, Pathogenesis of Vascular Infections, 75015, Paris, France. guillaume.dumenil@pasteur.fr.ORCID 0000-0001-9174-9110
Inserm · FRCentre National de la Recherche Scientifique · FRInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type IV pili (T4P) are prevalent, polymeric surface structures in pathogenic bacteria, making them ideal targets for effective vaccines. However, bacteria have evolved efficient strategies to evade type IV pili-directed antibody responses. Neisseria meningitidis are prototypical type IV pili-expressing Gram-negative bacteria responsible for life threatening sepsis and meningitis. This species has evolved several genetic strategies to modify the surface of its type IV pili, changing pilin subunit amino acid sequence, nature of glycosylation and phosphoforms, but how these modifications affect antibody binding at the structural level is still unknown. Here, to explore this question, we determine cryo-electron microscopy (cryo-EM) structures of pili of different sequence types with sufficiently high resolution to visualize posttranslational modifications. We then generate nanobodies directed against type IV pili which alter pilus function in vitro and in vivo. Cyro-EM in combination with molecular dynamics simulation of the nanobody-pilus complexes reveals how the different types of pili surface modifications alter nanobody binding. Our findings shed light on the impressive complementarity between the different strategies used by bacteria to avoid antibody binding. Importantly, we also show that structural information can be used to make informed modifications in nanobodies as countermeasures to these immune evasion mechanisms.

Indexed as

Single-Domain AntibodiesAmino Acid SequenceCryoelectron MicroscopyFimbriae, BacterialFimbriae ProteinsFimbriae ProteinsSingle-Domain Antibodies

Identifiers

PMID38499587
PMCPMC10948894
OpenAlexW4392896981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.